Eternity in Medical Information -- Medisurf
Search | Web Directory, News, Variable useful Information, PubMed In Medine, All
Category Select :
Items 161 ~ 180 of 25816, Page 9 of 1292
161. Novel Technique May Significantly Reduce Breast Biopsies
A combination of three-compartment breast image analysis and radiomics may improve cancer diagnosis and reduce breast biopsies...
12/11/2018 Radiological Society of North America
162. Statement from FDA Commissioner Scott Gottlieb, M.D., on new actions advancing the agency’s biosimilars policy framework
12/11/2018 U.S. FOOD & DRUG ADMINISTRATION
163. FDA warns API manufacturer involved in valsartan recall, provides information for patients taking these medications
12/11/2018 U.S. FOOD & DRUG ADMINISTRATION
164. Digital Mammography Increases Breast Cancer Detection
Digital mammography increased cancer detection by an overall rate of 14 percent in a large UK study...
12/11/2018 Radiological Society of North America
165. Abbott to Present at J.P. Morgan Healthcare Conference
ABBOTT PARK, Ill., Dec. 11, 2018 /PRNewswire/ --?Abbott (NYSE: ABT)?will present at the 37th Annual J.P. Morgan Healthcare Conference on Tuesday, Jan. 8, 2019. Brian Yoor, executive vice president of finance and Chief Financial Officer, will present at the conference at 11 a.m. Central time.
12/11/2018 Abbott
166. Statement from FDA Commissioner Scott Gottlieb, M.D. and Deputy Commissioner Anna Abram on new efforts to assure the quality of compounded drugs
12/10/2018 U.S. FOOD & DRUG ADMINISTRATION
167. FDA clears mobile medical app to help those with opioid use disorder stay in recovery programs
12/10/2018 U.S. FOOD & DRUG ADMINISTRATION
168. New Drug Reduces Recurrence Risk for Some Women With Early-Stage Breast Cancer
Study compares Kadcyla (T-DM1) to Herceptin (Trastuzumab)
12/10/2018 American Cancer Society
169. Statement from Jeff Shuren, M.D., J.D., Director of the Center for Devices and Radiological Health, on updated safety communication about rates of duodenoscope contamination from preliminary postmarket data
12/10/2018 U.S. FOOD & DRUG ADMINISTRATION
170. Merck’s President of Global Human Health Adam H. Schechter to Leave Merck Frank Clyburn Named Chief Commercial Officer and Michael Nally Named Chief Marketing Officer
12/10/2018 MERCK
171. Medtronic Named One of America''s Best Corporate Citizens in 2018 by Forbes Magazine
DUBLIN - December 10, 2018 -?Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has been named one of America''s Most JUST Companies in 2018, according to?Forbes?magazine and JUST Capital, a nonprofit that ranks publicly-traded corporations on the issues Americans care about most. Medtronic was ranked 61st?on this year''s JUST 100: America''s Best Corporate Citizens list for outperforming its peers in areas such as fair treatment of employees, job creation, customer treatment, and product quality.
12/10/2018 Medtronic
172. American Academy of Ophthalmology Calls on States to Maintain High Safety Standards for Surgical Eye Care
Nation’s eye physicians and surgeons support executive branch’s emphasis on patient safety as state lawmakers weigh scope-of-practice expansion
12/10/2018 American Academy of Ophthalmology
173. Medtronic Announces Cash Dividend for Third Quarter of Fiscal Year 2019
DUBLIN - December 7, 2018 -?The board of directors of?Medtronic?plc?(NYSE:MDT) today approved the fiscal year 2019 third quarter cash dividend of $0.50 per ordinary share, representing a 9 percent increase over the prior year. This quarterly declaration is consistent with the dividend announcement made by the company in June 2018. Medtronic is a constituent of the S&P 500 Dividend Aristocrats index, having increased its annual dividend payment for the past 41 consecutive years. The dividend is payable on January 18, 2019, to shareholders of record at the close of business on December 28, 2018.
12/07/2018 Medtronic
174. Statement from FDA Commissioner Scott Gottlieb, M.D., on the FDA’s new effort for developing and class labeling of in vitro companion diagnostics for classes of oncology therapeutic products
One challenge we face right now, when it comes to developing diagnostics that can help target the delivery of cancer drugs, is the way these diagnostics are sometimes labeled.
12/06/2018 U.S. FOOD & DRUG ADMINISTRATION
175. Statement from FDA Commissioner Scott Gottlieb, M.D., on FDA’s new strategic framework to advance use of real-world evidence to support development of drugs and biologics
12/06/2018 U.S. FOOD & DRUG ADMINISTRATION
176. FDA Approves First Biosimilar for Non-Hodgkin Lymphoma
The US Food and Drug Administration (FDA) has approved Truxima (rituximab-abbs), the first biosimilar drug to treat adults with some types of non-Hodgkin lymphoma.
12/06/2018 American Cancer Society
177. Decline Stalls: 58 Million Americans Still Exposed to Secondhand Smoke
Exposure remains high for certain groups, including kids
12/06/2018 Centers for Disease Control and Prevention
178. AAOS Encouraged by Administration’s Plan to Promote Healthcare Competition
12/06/2018 American Academy of Orthopaedic Surgeons
179. Health benefits far outweigh the costs of meeting climate change goals
12/05/2018 WHO
180. FDA takes new action to advance the development of reliable and beneficial genetic tests that can improve patient care
12/04/2018 U.S. FOOD & DRUG ADMINISTRATION
   
1 2 3 4 5 6 7 8 9 10
 
경기도 성남시 분당구 구미동 25-1 엘레강스 프라자 ㈜ 메디서프 | Tel : 031-896-0930 | 사업자 등록번호 : 212-81-47247
통신판매신호번호 : 경기 성남 2007-712 | 대표이사 한상욱